KOSDAQ · 092730
Neopharm
Market cap₩352B
PER11.48×
PBR1.71×
Foreign ownership25.99%
Avg. analyst target₩30,500
Pension summary
as of Oct 26streak3-day net buy
5D+₩380M
20D+₩470M
60D+₩1.5B
Foreign 20D-₩2.2B
Inst. 20D+₩4.5B
Pension daily net buy
-Cumulative net buying by investor
-선택 기간의 net buy Total · ₩100M
| Date | Close | Pension funds | Foreign | Institutions | Retail |
|---|---|---|---|---|---|
| 10/26 | 21,950 | +₩230M | -₩340M | +₩230M | +₩100M |
| 10/23 | 23,250 | +₩70M | -₩370M | +₩390M | -₩20M |
| 10/22 | 23,250 | +₩60M | -₩110M | +₩180M | -₩70M |
| 10/21 | 22,950 | – | -₩90M | +₩40M | +₩50M |
| 10/20 | 23,150 | +₩20M | -₩140M | +₩80M | +₩50M |
| 10/19 | 23,550 | +₩150M | -₩380M | +₩560M | -₩170M |
| 10/16 | 23,000 | +₩90M | +₩20M | +₩560M | -₩580M |
| 10/15 | 22,100 | – | +₩170M | +₩290M | -₩450M |
| 10/14 | 22,400 | – | -₩230M | +₩140M | +₩70M |
| 10/13 | 22,600 | – | +₩310M | +₩410M | -₩700M |
Discussion
Google-verified members · return since posting- Loading
세력 매집
last 60 trading days · Oct 23Foreign 60D−₩4.6B
Pension funds 60D+₩1.2B
세력 Avg. cost23,310
vs. cost Close-0.7%
Foreign+Pension funds Total 시총의 -0.9%, 60D price 폭 31%·Chg +24.3%. 세력 Avg. cost net buy한 날의 Avg 매수단가로 낸 est.치예요.
세력 매집 구간 All →ETF
ETFs holding it in their top 10 · recent changes10/08 이후 큰 ETF 변화는 없어요
All ETF index changes →Recent filings
DART- Loading
Broker price targets
Recent 1YRecent reports
- 더마 명가의 자부심, 제로이드Hana Securities · 09/17
- 치고 나가는 수출Hana Securities · 06/25
- [AI] 피부과학 기반 더마코스메틱 전문기업Korea IR Council · 04/27
- 탐방 노트: 국내외 고른 Growth+안정적 포트폴리오Kyobo Securities · 12/15
- Corporate Day 후기: 해외 Growth 가시화Yuanta Securities Korea · 11/14
Latest report per broker in the past year · Source: Naver Securities Research, Hankyung Consensus · Analyst names masked
Same sector
Neopharm summary
Neopharm (092730). Pension funds: +₩470M over the last 20 trading days; 3-day net buying streak. Market cap ₩352B, PER 11.48×, PBR 1.71×. Avg. analyst target ₩30,500. Pension flows are based on Korea Exchange investor statistics, for reference only.